Table 1. Clinical characteristics of the study population (n = 35). Pathologic characteristics are from institutional clinical pathologic assessment without central review.
| Age at diagnosis | 75 yr (mean) - 43-95 yrs (range) |
|---|---|
| ER Status | |
| ER positive (Allred 7) | 7 |
| ER positive (Allred 8) | 28 |
| HER2 Status | |
| HER2 positive | 3 |
| HER2 negative | 32 |
| Histological Grade | |
| 1 | 2 |
| 2 | 22 |
| 3 | 11 |
| Lymph Node Status | |
| Positive | 14 |
| Negative | 20 |
| Unknown (no surgery) | 1 |
| Menopausal Status | |
| Pre | 1 |
| Post | 34 |
| Surgery | |
| Wide local excision | 23 |
| Mastectomy | 11 |
| No surgery | 1 |
| Adjuvant Therapy | |
| Endocrine Therapy | 35 |
| Chemotherapy | 6 |
| Radiotherapy | 17 |